Figure 5From: ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel BRCA1 mRNA expression levels (logarithmically transformed) were negatively correlated with resistance to docetaxel in 20 NSCLC patients (P = 0.008, r = -0.573). Back to article page